95 related articles for article (PubMed ID: 2780710)
1. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock.
Bonavida B; Paubert-Braquet M; Hosford D; Braquet P
Prog Clin Biol Res; 1989; 308():485-9. PubMed ID: 2780710
[No Abstract] [Full Text] [Related]
2. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
[TBL] [Abstract][Full Text] [Related]
3. Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models.
Bahr T; Schaper U; Becker K; Lueddeckens G; Förster W; Scheuch DW; Grupe R
Prog Clin Biol Res; 1989; 301():229-33. PubMed ID: 2798447
[No Abstract] [Full Text] [Related]
4. Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cells.
Hunyadi J; Kenderessy AS; Duda E; Braquet P; Dobozy A
Mol Immunol; 1993 Apr; 30(6):517-9. PubMed ID: 7683748
[TBL] [Abstract][Full Text] [Related]
5. Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins.
Braquet P; Hosford D; Koltz P; Guilbaud J; Paubert-Braquet M
Lipids; 1991 Dec; 26(12):1071-5. PubMed ID: 1668107
[TBL] [Abstract][Full Text] [Related]
6. Lethal and non-lethal course of endotoxic shock is determined by interactions between tumor necrosis factor, platelet activating factor and eicosanoids.
Mozes T; Ben-Efraim S; Bonta IL
Pathol Biol (Paris); 1992 Oct; 40(8):807-12. PubMed ID: 1484741
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha 'primes' the platelet-activating factor-induced superoxide production by human neutrophils: possible involvement of G proteins.
Paubert-Braquet M; Hosford D; Klotz P; Guilbaud J; Braquet P
J Lipid Mediat; 1990; 2 Suppl():S1-4. PubMed ID: 1966810
[TBL] [Abstract][Full Text] [Related]
8. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.
Koltai M; Hosford D; Braquet P
J Lipid Mediat; 1993; 6(1-3):183-98. PubMed ID: 8357981
[No Abstract] [Full Text] [Related]
9. Myoelectric intestinal disturbances in Escherichia coli endotoxic shock in rats. Involvement of platelet-activating factor.
Pons L; Droy-Lefaix MT; Braquet P; Buéno L
Lipids; 1991 Dec; 26(12):1359-61. PubMed ID: 1819734
[TBL] [Abstract][Full Text] [Related]
10. Enhanced human monocyte cytotoxicity by platelet-activating factor.
Valone FH; Philip R; Debs RJ
Immunology; 1988 Aug; 64(4):715-8. PubMed ID: 3169845
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor induces the production of leukotrienes by human monocytes.
Fauler J; Sielhorst G; Frölich JC
Biochim Biophys Acta; 1989 Sep; 1013(1):80-5. PubMed ID: 2790041
[TBL] [Abstract][Full Text] [Related]
12. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
[TBL] [Abstract][Full Text] [Related]
13. Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor.
Bonavida B; Mencia-Huerta JM; Braquet P
Int Arch Allergy Appl Immunol; 1989; 88(1-2):157-60. PubMed ID: 2707879
[TBL] [Abstract][Full Text] [Related]
14. PAF-cytokine autocatalytic feed-back network in septic shock: involvement in acute renal failure.
Koltai M; Pirotzky E; Braquet P
Nephrol Dial Transplant; 1994; 9 Suppl 4():69-72. PubMed ID: 7800272
[No Abstract] [Full Text] [Related]
15. Role of PAF and cytokines in microvascular tissue injury.
Koltai M; Hosford D; Braquet P
J Lab Clin Med; 1992 May; 119(5):461-6. PubMed ID: 1316420
[No Abstract] [Full Text] [Related]
16. Endotoxin shock, kinin system and PAF-acether in the rat.
Damas J; Remacle-Volon G; Adam A; Bourdon V
Adv Exp Med Biol; 1989; 247B():547-52. PubMed ID: 2610092
[No Abstract] [Full Text] [Related]
17. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
Bahrami S; Redl H; Thurnher M; Vogl C; Paul E; Schiesser A; Schlag G
Prog Clin Biol Res; 1989; 308():931-6. PubMed ID: 2780740
[No Abstract] [Full Text] [Related]
18. Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor.
Ruis NM; Rose JK; Valone FH
Lipids; 1991 Dec; 26(12):1060-4. PubMed ID: 1668105
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of PAF-induced tPA release by KO-286011.
Klöcking HP
Ann N Y Acad Sci; 1992 Dec; 667():202-3. PubMed ID: 1309038
[No Abstract] [Full Text] [Related]
20. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.
Mandi Y; Farkas G; Koltai M; Beladi I; Mencia-Huerta JM; Braquet P
Immunology; 1989 Jul; 67(3):370-4. PubMed ID: 2759659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
